English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/173619
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Epigenetic dysregulation of TET2 in human glioblastoma

AuthorsGarcía, María G.; Carella, Antonella; Urdinguio, Rocío G.; Bayón, Gustavo F.; López, Virginia; Tejedor, Juan Ramón; Sierra, Marta I.; García-Toraño, Estela; Santamarina-Ojeda, Pablo; Pérez, Raúl F.; Mangas, Cristina; Astudillo, Aurora; Corte-Torres, M. Daniela; Sáenz-de-Santa-María, Inés; Chiara, María-Dolores; Fernández, Agustín F.; Fraga, Mario F.
DNA methylation
Issue Date2018
PublisherImpact Journals
CitationOncotarget 9(40): 25922-25934 (2018)
AbstractTen-eleven translocation (TET) enzymes are frequently deregulated in cancer, but the underlying molecular mechanisms are still poorly understood. Here we report that TET2 shows frequent epigenetic alterations in human glioblastoma including DNA hypermethylation and hypo-hydroxymethylation, as well as loss of histone acetylation. Ectopic overexpression of TET2 regulated neural differentiation in glioblastoma cell lines and impaired tumor growth. Our results suggest that epigenetic dysregulation of TET2 plays a role in human glioblastoma.
Publisher version (URL)https://doi.org/10.18632/oncotarget.25406
Identifiersdoi: 10.18632/oncotarget.25406
e-issn: 1949-2553
Appears in Collections:(CINN) Artículos
Files in This Item:
File Description SizeFormat 
epiTET2toma.pdf2,74 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.